Treating Liver Fibrosis in 2025: Prime Time or Are We Still in the Commercial Break?
Nov
16
2024
Convention Center: Ballroom 6C
8:00 AM - 9:30 AM
Captured
World Class Speakers
Description
This program reviews recent updates in the rapidly evolving area of liver fibrosis treatment. Topics addressed by the expert presenters include an overview of the different therapeutic targets from metabolism to matrix; the goal of reversing rather than halting liver fibrosis; restoration of liver function in addition to antifibrogenic treatment and novel concepts that link the two; and personalized and combination therapy with a specific focus on metabolism.Presentations
8:00 AM - 8:15 AM
Nov
16
2024
San Diego, CA
Update on Different Classes of Antifibrotics: From Metabolism to Matrix
Scott L. Friedman, MD, FAASLD, Presenter
8:15 AM - 8:30 AM
Nov
16
2024
San Diego, CA
Reversibility of Fibrosis: Timing Is Everything
Manal F Abdelmalek, MD, MPH, FAASLD, Presenter
8:30 AM - 8:45 AM
Nov
16
2024
San Diego, CA
Beyond Extracellular Matrix and Fibrosis: Restoring Balance and Liver Function
Robert Schwabe, MD, Presenter
8:45 AM - 9:00 AM
Nov
16
2024
San Diego, CA
The Who and How of Treating Liver Fibrosis: Clues for Personalized and Combination Therapy
Jonathan A Fallowfield, BSc (Hons), BM (Hons), PhD, MRCP, Presenter
Objectives
- List different treatment options for hepatic fibrosis.
- Review the underlying mechanisms of hepatic fibrosis reversibility and restoration of liver function, and how this can be achieved in patients.
- Identify personalized treatments as well as combination and sequential therapies for hepatic fibrosis.